Sebela Pharmaceuticals receives FDA approval for Sutab tablets for colonoscopy preparation

Sebela Pharmaceuticals

10 November 2020 - Sebela Pharmaceuticals today announces that the U.S. FDA approved Sutab (sodium sulphate, magnesium sulphate and potassium chloride) tablets. 

Sutab gives patients and physicians an alternative to liquid-based colonoscopy preparations.

Read Sebela Pharmaceuticals press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , Medicine , US